التفاصيل البيبلوغرافية
| العنوان: |
Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fusion. |
| المؤلفون: |
Xianglei Gao, Wei Chen, Chaowan Guo, Chuiwen Qian, Ge Liu, Feng Ge, Yadong Huang, Kaio Kitazato, Yifei Wang, Sheng Xiong |
| المصدر: |
Applied Microbiology & Biotechnology; Jan2010, Vol. 85 Issue 4, p1051-1060, 10p, 2 Diagrams, 1 Chart, 3 Graphs |
| مصطلحات موضوعية: |
ESCHERICHIA coli, FOODBORNE diseases, CYTOPLASM, PROTOPLASM, MOLECULAR weights, HERPES simplex virus, PHYSICAL & theoretical chemistry, CHROMATOGRAPHIC analysis, ENTEROBACTERIACEAE, SPECTROMETRY |
| مستخلص: |
Cyanovirin-N (CVN) is a promising antiviral candidate that has an extremely low sequence homology with any other known proteins. The efficient and soluble expression of biologically functional recombinant CVN (rCVN) is still an obstacle due to insufficient yield, aggregation, and abnormal modification. Here, we describe an improved approach to preparing native rCVN from Escherichia coli more efficiently. A fusion gene consisting of cvn and sumo (small ubiquitin-related modifier) and a hexahistidine tag was constructed according to the codon bias of the host cell. This small ubiquitin-related modifier (SUMO)-fused CVN is expressed in the cytoplasm of E. coli in a folded and soluble form (>30% of the total soluble protein), yielding 3 to 4 mg of native rCVN from 1 g of wet cells to a purity up to 97.6%. Matrix-assisted laser desorption ionization coupled to time-of-flight mass spectrometry and reverse-phase high-performance liquid chromatographic analysis showed that the purified rCVN was an intact and homogeneous protein with a molecular weight of 11,016.68 Da. Potent antiviral activity of rCVN against herpes simplex virus type 1 and human immunodeficiency virus type 1/IIIB was confirmed in a dose-dependent manner at nanomolar concentrations. Thus, the His-SUMO double-fused CVN provides an efficient approach for the soluble expression of rCVN in the cytoplasm of E. coli, allowing an alternative system to develop bioprocess for the large-scale production of this antiviral candidate. [ABSTRACT FROM AUTHOR] |
|
Copyright of Applied Microbiology & Biotechnology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder